Matthias von Herrath, M.D.
Vice President, and Senior Medical Officer, Global Chief Medical Office Novonordisk
Professor at the La Jolla Institute
1988 – MD from the University of Freiburg, Germany
1988-1991 – Residency in Internal and emergency medicine
1991-1995 – Postdoctoral DFG and JDRF fellowships at Scripps with Michael Oldstone –
Immunology and Virology
1995-1999 – Assistant Professor at Scripps – Viral autoimmunity
1999-2001 – Associate Professor at Scripps
2001-2005 – Associate Professor with Tenure – La Jolla Institute
2005 – present - Professor and Director, Type 1 Research Center at La Jolla Institute
2008 – ADA Outstanding Scientific Achievement Award
2012 – Vice President and Head NovoNordisk Type 1 diabetes Research Center Seattle
2014 and 2018 – Ranked as Type 1 leading investigator by Expertscape at ADA
2014 – Paul Langerhans Medal from German Diabetes Sociaty (DDG)
2017- 2018 – Vice President for Type 1 Diabetes and Kidney Disease NNRCS Seattle
2018 – present Vice president and Senior Medical Officer, Global Chief Medical Office, Novonordisk – section type 1 diabetes and stem cells with focus on complications
2019 - Standing member of NIH HAI study section
2016 – present - Member of the Germen Excellence Initiative review committee
Novo Nordisk Pharma GmbH
United States
Session
Immunintervention zur Vorbeugung und Therapie des Typ-1-Diabetes
Vorsitz